25.16
-0.58 (-2.25%)
| 前收盘价格 | 25.74 |
| 收盘价格 | 26.02 |
| 成交量 | 581,493 |
| 平均成交量 (3个月) | 820,698 |
| 市值 | 1,161,717,760 |
| 预期市盈率 (P/E Forward) | 9.44 |
| 价格/销量 (P/S) | 1.70 |
| 股市价格/股市净资产 (P/B) | 1.54 |
| 52周波幅 | |
| 利润日期 | 27 Feb 2025 |
| 营业毛利率 | -14.20% |
| 营业利益率 (TTM) | 15.77% |
| 稀释每股收益 (EPS TTM) | -2.15 |
| 季度收入增长率 (YOY) | 3.30% |
| 季度盈利增长率 (YOY) | -35.50% |
| 总债务/股东权益 (D/E MRQ) | 82.08% |
| 流动比率 (MRQ) | 2.40 |
| 营业现金流 (OCF TTM) | 189.39 M |
| 杠杆自由现金流 (LFCF TTM) | 163.38 M |
| 资产报酬率 (ROA TTM) | 3.90% |
| 股东权益报酬率 (ROE TTM) | -12.08% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Drug Manufacturers - Specialty & Generic (US) | 混合的 | 混合的 |
| Drug Manufacturers - Specialty & Generic (全球的) | 混合的 | 混合的 | |
| 股票 | Pacira BioSciences, Inc. | 看涨 | 看涨 |
AIStockmoo 评分
| 分析师共识 | -1.5 |
| 内部交易活动 | NA |
| 价格波动 | -2.0 |
| 技术平均移动指标 | -1.0 |
| 技术振荡指标 | 2.0 |
| 平均 | -0.63 |
|
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. |
|
| 部门 | Healthcare |
| 行业 | Drug Manufacturers - Specialty & Generic |
| 投资方式 | Small Value |
| 内部持股比例 | 3.09% |
| 机构持股比例 | 112.01% |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 65.00 (HC Wainwright & Co., 158.35%) | 购买 |
| 中 | 28.50 (13.28%) | |
| 低 | 24.00 (Barclays, -4.61%) | 购买 |
| 平均值 | 36.50 (45.07%) | |
| 总计 | 3 购买, 1 保留 | |
| 平均价格@调整类型 | 25.71 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| HC Wainwright & Co. | 08 Apr 2025 | 65.00 (158.35%) | 购买 | 26.27 |
| 28 Feb 2025 | 70.00 (178.22%) | 购买 | 24.05 | |
| Needham | 08 Apr 2025 | 32.00 (27.19%) | 购买 | 26.27 |
| 28 Feb 2025 | 32.00 (27.19%) | 购买 | 24.05 | |
| Barclays | 28 Feb 2025 | 24.00 (-4.61%) | 购买 | 24.05 |
| Truist Securities | 30 Jan 2025 | 25.00 (-0.64%) | 保留 | 26.24 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合